Gapping down
In reaction to earnings/guidance:
- SCHL -9.9%, SCS -7.3%, AIR -3.3%, X -3% (guides Q4 EPS and EBITDA below consensus), FDX -3%, CNC -3% (guidance) BB -2.2%, DRI -2.1%
Other news:
- MESO -29.3% (provides update on COVID-19 ARDS trial)
- GLSI -11.4% (priced $26.4 mln upsized public offering of common stock)
- EGLE -8.2% (stock offering)
- CKPT -5.8% (launched $100 mln at-the-market offering)
- ASUR -2.9% (stock offering)
- PRSP -2.6% (awarded $800 mln Navy contract)
- INN -2.1% (new CEO)
- UPS -1.4% (in sympathy with FDX earnings report)
- MRNA -1.4% (confirms receipt of FDA Advisory Committee vote supporting EUA for mRNA-1273)
- PRAH -1.1% (PRAH enhances COVID-19 monitoring program via collaboration with FLGT and PWNHealth)
Analyst comments:
- PLTR -3% (downgraded to Underperform from Neutral at Credit Suisse)
- CAMP -2.8% (downgraded to Underweight from Neutral at JP Morgan)
- CLB -1.9% (downgraded to Underweight from Neutral at JP Morgan)
- DISCA -1.9% (downgraded to Underperform from Buy at BofA Securities)
- VIAC -1.6% (downgraded to Underperform from Neutral at BofA Securities)
- AEG -1.3% (downgraded to Neutral from Outperform at Credit Suisse)
- XRAY -1.1% (downgraded to Hold from Buy at Stifel)
- MBT -1% (downgraded to Neutral from Buy at New Street)
- DX -0.9% (downgraded to Mkt Perform from Outperform at Keefe Bruyette)
- IHRT -0.8% (downgraded to Underperform from Neutral at BofA Securities)
- SAFM -0.6% (downgraded to Neutral from Buy at Goldman)